These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 26319884)
21. Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA. Martinot-Peignoux M; Lapalus M; Laouénan C; Lada O; Netto-Cardoso AC; Boyer N; Ripault MP; Carvalho-Filho R; Asselah T; Marcellin P J Clin Virol; 2013 Oct; 58(2):401-7. PubMed ID: 24004660 [TBL] [Abstract][Full Text] [Related]
22. A serum microRNA signature is associated with the immune control of chronic hepatitis B virus infection. Brunetto MR; Cavallone D; Oliveri F; Moriconi F; Colombatto P; Coco B; Ciccorossi P; Rastelli C; Romagnoli V; Cherubini B; Teilum MW; Blondal T; Bonino F PLoS One; 2014; 9(10):e110782. PubMed ID: 25350115 [TBL] [Abstract][Full Text] [Related]
23. Serum hepatitis B surface antigen levels correlate with high serum HBV DNA levels in patients with chronic hepatitis B: a cross-sectional study. Gupta E; Kumar A; Choudhary A; Kumar M; Sarin SK Indian J Med Microbiol; 2012; 30(2):150-4. PubMed ID: 22664428 [TBL] [Abstract][Full Text] [Related]
24. Hepatitis B Virus-Encoded MicroRNA Controls Viral Replication. Yang X; Li H; Sun H; Fan H; Hu Y; Liu M; Li X; Tang H J Virol; 2017 May; 91(10):. PubMed ID: 28148795 [TBL] [Abstract][Full Text] [Related]
25. Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection? Papatheodoridis GV; Manesis EK; Manolakopoulos S; Elefsiniotis IS; Goulis J; Giannousis J; Bilalis A; Kafiri G; Tzourmakliotis D; Archimandritis AJ Hepatology; 2008 Nov; 48(5):1451-9. PubMed ID: 18924246 [TBL] [Abstract][Full Text] [Related]
26. Association between serum S100A9 levels and liver necroinflammation in chronic hepatitis B. Wu R; Zhang Y; Xiang Y; Tang Y; Cui F; Cao J; Zhou L; You Y; Duan L J Transl Med; 2018 Apr; 16(1):83. PubMed ID: 29615081 [TBL] [Abstract][Full Text] [Related]
27. Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection. Papatheodoridis GV; Chrysanthos N; Hadziyannis E; Cholongitas E; Manesis EK J Viral Hepat; 2008 Jun; 15(6):434-41. PubMed ID: 18194171 [TBL] [Abstract][Full Text] [Related]
28. Modulation of serum interleukin-18 concentrations and hepatitis B virus DNA levels during interferon therapy in patients with hepatitis B e-antigen-positive chronic hepatitis B. Sylvan SP; Hellstrom UB J Interferon Cytokine Res; 2010 Dec; 30(12):901-8. PubMed ID: 20973680 [TBL] [Abstract][Full Text] [Related]
29. Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters. Tseng TC; Liu CJ; Yang WT; Chen CL; Yang HC; Su TH; Wang CC; Kuo SF; Liu CH; Chen PJ; Chen DS; Kao JH J Gastroenterol Hepatol; 2014 Jun; 29(6):1242-9. PubMed ID: 24384028 [TBL] [Abstract][Full Text] [Related]
30. [Comparison of quantitative hepatitis B virus DNA levels in serum and liver biopsy samples of chronic hepatitis B patients]. Rüzgar M; Cetin Akhan S; Vahaboğlu H Mikrobiyol Bul; 2008 Apr; 42(2):283-91. PubMed ID: 18697426 [TBL] [Abstract][Full Text] [Related]
31. Decreasing hepatitis B viral load is associated with a risk of significant liver fibrosis in hepatitis B e antigen positive chronic hepatitis B. Xie Q; Hu X; Zhang Y; Jiang X; Li X; Li J J Med Virol; 2014 Nov; 86(11):1828-37. PubMed ID: 25145769 [TBL] [Abstract][Full Text] [Related]
32. Loss of microRNA 122 expression in patients with hepatitis B enhances hepatitis B virus replication through cyclin G(1) -modulated P53 activity. Wang S; Qiu L; Yan X; Jin W; Wang Y; Chen L; Wu E; Ye X; Gao GF; Wang F; Chen Y; Duan Z; Meng S Hepatology; 2012 Mar; 55(3):730-41. PubMed ID: 22105316 [TBL] [Abstract][Full Text] [Related]
33. Correlation between circulating miR-122 and prognosis of chronic HBV-related liver failure. Wang WJ; Lai RT; Lu J; Xiang XG; Zhao GD; Tang WL; Cai W; Wang H; Zhou HJ; Xie Q J Dig Dis; 2016 May; 17(5):334-9. PubMed ID: 27059663 [TBL] [Abstract][Full Text] [Related]
34. [Serum ALT and HBV DNA levels in patients with HBeAg-negative chronic hepatitis B]. Kim KH; Na IH; Cha JM; Cho YK; Park SY; Kim HP; Song CS; Heo J; Cho M Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):284-92. PubMed ID: 14695695 [TBL] [Abstract][Full Text] [Related]
35. Clinical relevance of HBV DNA load in patients with chronic hepatitis B infection. Madan K; Batra Y; Jha JK; Kumar S; Kalra N; Paul SB; Singh R; Duttagupta S; Panda SK; Acharya SK Trop Gastroenterol; 2008; 29(2):84-90. PubMed ID: 18972767 [TBL] [Abstract][Full Text] [Related]
36. Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers. Thompson AJ; Nguyen T; Iser D; Ayres A; Jackson K; Littlejohn M; Slavin J; Bowden S; Gane EJ; Abbott W; Lau GK; Lewin SR; Visvanathan K; Desmond PV; Locarnini SA Hepatology; 2010 Jun; 51(6):1933-44. PubMed ID: 20512987 [TBL] [Abstract][Full Text] [Related]
37. The importance of the serum quantitative levels of hepatitis B surface antigen and hepatitis B e antigen in children with chronic hepatitis B. Demirören K; Kocamaz H; Doğan Y Turk J Gastroenterol; 2015 Jan; 26(1):36-41. PubMed ID: 25698269 [TBL] [Abstract][Full Text] [Related]
38. Role of hepatitis B surface antigen (HBsAg) in identifying true inactive HBsAg carriers infected with genotype C hepatitis B virus. Yim SY; Um SH; Jung JY; Seo YS; Yim HJ; Ryu HS; Chun HJ; Jeen YT; Kim CD; Keum B; Lee HS J Clin Gastroenterol; 2014 Feb; 48(2):166-71. PubMed ID: 24045280 [TBL] [Abstract][Full Text] [Related]
39. Hepatitis B surface antigen seroclearance in patients with chronic hepatitis B infection: a clinical study. Ruan P; Xu SY; Zhou BP; Huang J; Gong ZJ J Int Med Res; 2013 Oct; 41(5):1732-9. PubMed ID: 23908397 [TBL] [Abstract][Full Text] [Related]
40. Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection. Bihrer V; Friedrich-Rust M; Kronenberger B; Forestier N; Haupenthal J; Shi Y; Peveling-Oberhag J; Radeke HH; Sarrazin C; Herrmann E; Zeuzem S; Waidmann O; Piiper A Am J Gastroenterol; 2011 Sep; 106(9):1663-9. PubMed ID: 21606975 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]